In keeping with this, miR-155, a canonical NF-κB regulated miRNA, was identified as a negative regulator of FOXO3a leading to increased gefitinib resistance and lung cancer stemness in vitro and in vivo [92]. The gene discussed is NFKB1; the disease is lung cancer.